BIIB BIOGEN INC
2026Q1 · CUSIP 09062X103 · Sector: Healthcare & Biotech
Cooling · Breadth rolling over
Holders
997
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
288
Δ whales
-8
Inst. holding value
$24.2B
New positions
135
Closed positions
134
Price momentum (1Q)
-1.9%
Put / Call
24/23
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 4% | -1.9% | — |
| 2025Q3 | Top 6% | +16.6% | +14.0% |
| 2023Q4 | Top 12% | +5.2% | -5.9% |
| 2022Q4 | Top 8% | +12.5% | -3.8% |
| 2022Q3 | Top 1% | -7.2% | +2.8% |
| 2021Q2 | Top 17% | -21.3% | -37.7% |
| 2021Q1 | Top 12% | +22.5% | -3.6% |
| 2019Q4 | Top 3% | -6.3% | -14.2% |
| 2018Q3 | Top 1% | -0.9% | -27.5% |
Options Sentiment
Put holders
24
QoQ: -2
Call holders
23
QoQ: -4
See methodology →
Fundamentals
PE (TTM)
20.6
EPS (TTM)
$9.30
EPS YoY
-8.1%
Revenue (TTM)
$9.9B
Revenue YoY
+1.2%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)